World's Best Scientists 2026 revealed!
Philippe R. S. Lagacé-Wiens

Philippe R. S. Lagacé-Wiens

D-Index & Metrics

Microbiology

D-Index
47
Citations
8466
World Ranking
4791
National Ranking
142

Philippe R. S. Lagacé-Wiens publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Philippe R. S. Lagacé-Wiens sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 187 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Philippe R. S. Lagacé-Wiens D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Philippe R. S. Lagacé-Wiens sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 47 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Philippe R. S. Lagacé-Wiens is affiliated with the University of Manitoba in Canada. Their work spans multiple fields related to medicine, with a particular focus on infectious diseases and antimicrobial research.

The main areas of study for Philippe R. S. Lagacé-Wiens include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their subfields of study further specify their expertise:

  • Epidemiology
  • Molecular Medicine
  • Infectious Diseases
  • Applied Microbiology and Biotechnology
  • Pharmacology

Their research largely addresses topics around bacterial resistance and antibiotic efficacy, including:

  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Antimicrobial Resistance in Staphylococcus
  • Urinary Tract Infections Management
  • Respiratory viral infections research

Frequent coauthors who have contributed with Philippe R. S. Lagacé-Wiens include:

  • Heather J. Adam
  • Andrew Walkty
  • George G. Zhanel
  • Melanie Baxter
  • James A. Karlowsky

The scientist has published in several recurring venues, reflecting their research interests and audience:

  • Journal of Antimicrobial Chemotherapy
  • Open Forum Infectious Diseases
  • Canadian Medical Association Journal
  • Drugs
  • Diagnostic Microbiology and Infectious Disease

Recent papers associated with Philippe R. S. Lagacé-Wiens include:

  • "Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent", 2020, Drugs
  • "Diagnostic testing for SARS-CoV-2", 2020, Canadian Medical Association Journal
  • "Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia", 2020, Drugs
  • "In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units", 2020, Diagnostic Microbiology and Infectious Disease
  • "Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria", 2022, Drugs

Best Publications

  • Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

    George G. Zhanel;George G. Zhanel;Christopher D. Lawson;Heather Adam;Heather Adam;Frank Schweizer

  • New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.

    George G. Zhanel;Divna Calic;Frank Schweizer;Sheryl Zelenitsky

  • Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

    George G. Zhanel;Alyssa R. Golden;Sheryl Zelenitsky;Karyn Wiebe

  • Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

    George G. Zhanel;Courtney K. Lawrence;Heather Adam;Frank Schweizer

  • Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli

    George G. Zhanel;George G. Zhanel;Phillip Chung;Heather Adam;Heather Adam;Sheryl Zelenitsky

  • Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

    George G. Zhanel;Mel DeCorby;Nancy Laing;Barb Weshnoweski

  • Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

    George G. Zhanel;George G. Zhanel;Doris Cheung;Heather J. Adam;Heather J. Adam;Sheryl A. Zelenitsky

  • Identification of Blood Culture Isolates Directly from Positive Blood Cultures by Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and a Commercial Extraction System: Analysis of Performance, Cost, and Turnaround Time

    Philippe R. S. Lagacé-Wiens;Heather J. Adam;James A. Karlowsky;Kimberly A. Nichol

  • Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008)

    George G. Zhanel;Melanie DeCorby;Heather Adam;Michael R. Mulvey

  • Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

    George G. Zhanel;George G. Zhanel;Riley Love;Heather Adam;Heather Adam;Alyssa Golden

  • Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections

    Philippe Lagacé-Wiens;Andrew Walkty;James A Karlowsky

  • Ceftaroline: A Novel Broad-spectrum Cephalosporin with Activity against Meticillin-resistant Staphylococcus aureus

    George G. Zhanel;Grace Sniezek;Frank Schweizer;Sheryl Zelenitsky

  • Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007–11

    Andrew J Denisuik;Philippe R S Lagacé-Wiens;Philippe R S Lagacé-Wiens;Johann D Pitout;Michael R Mulvey;Michael R Mulvey

  • Antimicrobial Resistance in Urinary Tract Pathogens in Canada from 2007 to 2009: CANWARD Surveillance Study

    James A. Karlowsky;Philippe R. S. Lagacé-Wiens;Patricia J. Simner;Melanie R. DeCorby

  • Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007–11 study

    George G Zhanel;Heather J Adam;Melanie R Baxter;Jeff Fuller

  • In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012.

    A. Walkty;H. Adam;M. Baxter;A. Denisuik

  • Influenza epidemiology--past, present, and future.

    Philippe R. S. Lagacé-Wiens;Ethan Rubinstein;Abba Gumel

  • Adverse reactions to β-lactam antimicrobials

    Philippe Lagacé-Wiens;Ethan Rubinstein

  • Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent

    George G. Zhanel;Jenine Esquivel;Sheryl Zelenitsky;Courtney K. Lawrence

  • Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases

    P. R. S. Lagacé-Wiens;F. Tailor;P. Simner;M. DeCorby

  • Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.

    Patricia J. Simner;George G. Zhanel;Johann Pitout;Franil Tailor

Frequent Co-Authors

George G. Zhanel
George G. Zhanel University of Manitoba
James A. Karlowsky
James A. Karlowsky University of Manitoba
Heather J. Adam
Heather J. Adam University of Manitoba
Andrew Walkty
Andrew Walkty University of Manitoba
Daryl J. Hoban
Daryl J. Hoban University of Manitoba
Michael R. Mulvey
Michael R. Mulvey University of Manitoba
Ethan Rubinstein
Ethan Rubinstein University of Manitoba
Joseph P. Lynch
Joseph P. Lynch University of California, Los Angeles
Patricia J. Simner
Patricia J. Simner Johns Hopkins University School of Medicine
Allison McGeer
Allison McGeer University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, exploring related online degrees can open doors to diverse career pathways. Individuals with unique backgrounds, including those seeking college degrees for felons, can find supportive programs that help them succeed in scientific and healthcare fields. This inclusivity broadens access to education and career advancement.

One promising route is becoming a healthcare specialist through programs like functional medicine nurse practitioner programs. These offer advanced clinical skills that complement microbiology knowledge, enabling careers focused on personalized patient care and integrative health approaches.

For those inclined toward medical data and coding, earning credentials as a certified professional coder can be a lucrative and stable choice. This path leverages a microbiology background to manage healthcare records and billing accurately, playing an essential role in medical administration.

Further, a bachelor of science in health information management salary reflects the growing value of professionals managing patient data, compliance, and healthcare technology. Combining microbiology expertise with health information management skills enhances employability in hospitals and research institutions.

Best Scientists Citing Philippe R. S. Lagacé-Wiens

Trending Scientists

Recently Published Articles